应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01501 瑛泰医疗
未开盘 10-21 16:08:20
30.600
+0.500
+1.66%
最高
31.060
最低
30.460
成交量
16.16万
今开
31.000
昨收
30.100
日振幅
1.99%
总市值
64.57亿
流通市值
64.57亿
总股本
2.11亿
成交额
498.61万
换手率
0.08%
流通股本
2.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
瑛泰医疗(01501.HK)向梁栋科授予182.3万股H股奖励股份
中金财经 · 10-12
瑛泰医疗(01501.HK)向梁栋科授予182.3万股H股奖励股份
瑛泰医疗(01501.HK)授出182.3万股H股奖励股份
智通财经 · 10-12
瑛泰医疗(01501.HK)授出182.3万股H股奖励股份
瑛泰医疗(01501)向董事长梁栋科授出182.3万股H股奖励股份
公告速递 · 10-12
瑛泰医疗(01501)向董事长梁栋科授出182.3万股H股奖励股份
瑛泰医疗拟“回A”,搭建A+H双资本运作平台,拓宽融资渠道
深圳商报·读创 · 10-12
瑛泰医疗拟“回A”,搭建A+H双资本运作平台,拓宽融资渠道
瑛泰医疗(01501):建议发行总数不超过3727.06万股A股
智通财经 · 10-11
瑛泰医疗(01501):建议发行总数不超过3727.06万股A股
瑛泰医疗(01501)董事会通过A股发行方案 拟募资18亿元拓展医疗器械产业布局
公告速递 · 10-11
瑛泰医疗(01501)董事会通过A股发行方案 拟募资18亿元拓展医疗器械产业布局
瑛泰医疗9月股份变动月报:股本维持不变
公告速递 · 10-07
瑛泰医疗9月股份变动月报:股本维持不变
瑛泰医疗(01501)公布最新董事会及专门委员会架构
公告速递 · 09-24
瑛泰医疗(01501)公布最新董事会及专门委员会架构
瑛泰医疗2026年第一次临时股东会全部议案获通过 董事会及专门委员会架构同步调整
公告速递 · 09-24
瑛泰医疗2026年第一次临时股东会全部议案获通过 董事会及专门委员会架构同步调整
瑛泰医疗(01501.HK):张鹏及黎云龙获委任为独立非执行董事
智通财经 · 09-24
瑛泰医疗(01501.HK):张鹏及黎云龙获委任为独立非执行董事
瑛泰医疗2026年中期营收5.96亿元,经调整净利润1.26亿元
公告速递 · 09-14
瑛泰医疗2026年中期营收5.96亿元,经调整净利润1.26亿元
瑛泰医疗(01501)拟1.73亿美元收购心瓣介入器械商约27.82%股权 目标公司2025年收入增逾一倍
公告速递 · 09-11
瑛泰医疗(01501)拟1.73亿美元收购心瓣介入器械商约27.82%股权 目标公司2025年收入增逾一倍
瑛泰医疗(01501)2026年9月24日召开临时股东大会 拟调整董事会及修订章程
公告速递 · 09-08
瑛泰医疗(01501)2026年9月24日召开临时股东大会 拟调整董事会及修订章程
瑛泰医疗2026年8月股份变动月报表:股本维持稳定
公告速递 · 09-02
瑛泰医疗2026年8月股份变动月报表:股本维持稳定
瑛泰医疗(01501):王瑞琴辞任公司非执行董事
智通财经 · 08-24
瑛泰医疗(01501):王瑞琴辞任公司非执行董事
瑛泰医疗(01501)多项董事会人事及治理结构调整 拟向董事长授出最多521万股H股奖励
公告速递 · 08-24
瑛泰医疗(01501)多项董事会人事及治理结构调整 拟向董事长授出最多521万股H股奖励
瑛泰医疗(01501)公布最新董事会及三大专门委员会成员名单
公告速递 · 08-24
瑛泰医疗(01501)公布最新董事会及三大专门委员会成员名单
瑛泰医疗(01501)发布2026年中期业绩:营收5.96亿元 同比增29% 毛利率升至61.13%
公告速递 · 08-24
瑛泰医疗(01501)发布2026年中期业绩:营收5.96亿元 同比增29% 毛利率升至61.13%
瑛泰医疗(01501)发布中期业绩,股东应占利润1.1亿元 同比增加11.97%
智通财经 · 08-24
瑛泰医疗(01501)发布中期业绩,股东应占利润1.1亿元 同比增加11.97%
瑛泰医疗(01501)定于8月24日审议2026年中期业绩及派息事宜
公告速递 · 08-12
瑛泰医疗(01501)定于8月24日审议2026年中期业绩及派息事宜
加载更多
公司概况
公司名称:
瑛泰医疗
所属市场:
SEHK
上市日期:
--
主营业务:
上海瑛泰医疗器械股份有限公司(原名:上海康德莱医疗器械股份有限公司)是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发,例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01501","market":"HK","secType":"STK","nameCN":"瑛泰医疗","latestPrice":30.6,"timestamp":1792570100003,"preClose":30.1,"halted":0,"volume":161600,"delay":0,"changeRate":0.01661129568106312,"floatShares":211000000,"shares":211000000,"eps":1.26,"marketStatus":"未开盘","change":0.5,"latestTime":"10-21 16:08:20","open":31,"high":31.06,"low":30.46,"amount":4986088,"amplitude":0.019934,"askPrice":30.6,"askSize":200,"bidPrice":30.44,"bidSize":400,"shortable":3,"etf":0,"ttmEps":1.257,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792632600000},"marketStatusCode":0,"adr":0,"listingDate":1573142400000,"exchange":"SEHK","adjPreClose":30.1,"dividendRate":0.00879,"openAndCloseTimeList":[[1792546200000,1792555200000],[1792558800000,1792569600000]],"volumeRatio":0.930661138308222,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603987","market":"SH","secType":"STK","nameCN":"康德莱","latestPrice":7.28,"timestamp":1792566000000,"preClose":7.32,"halted":0,"volume":3191500,"delay":0,"premium":"+257.49"}},"requestUrl":"/m/hq/s/01501","defaultTab":"news","newsList":[{"id":"2674805319","title":"瑛泰医疗(01501.HK)向梁栋科授予182.3万股H股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2674805319","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674805319?lang=zh_cn&edition=full","pubTime":"2026-10-12 22:17","pubTimestamp":1791814621,"startTime":"0","endTime":"0","summary":"格隆汇10月12日丨瑛泰医疗(01501.HK)宣布,于2026年10月12日,董事会根据该计划的规则、股东于2022年5月16日举行的股东周年大会上授予董事会办理该计划相关事宜的授权,以及股东于临时股东会上批准的经提高的梁栋科个人限额,决议向梁栋科授予合共182.3万股H股奖励股份(“本次授予”)。本次授予连同于2026年6月28日向梁博士授出的3.34万股H股,合共185.64万股H股,在股东于临时股东会上批准的梁栋科于该计划项下经提高的个人限额(即521万股H股)范围内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261012/32394420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674803256","title":"瑛泰医疗(01501.HK)授出182.3万股H股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2674803256","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674803256?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:59","pubTimestamp":1791813567,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113798537","title":"瑛泰医疗(01501)向董事长梁栋科授出182.3万股H股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1113798537","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113798537?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:56","pubTimestamp":1791813384,"startTime":"0","endTime":"0","summary":"瑛泰医疗器械股份有限公司10月12日公告称,董事会当日根据H股奖励信托计划,向董事长、执行董事兼总经理梁栋科博士授出1,823,000股H股奖励股份。本次授予占公告日公司已发行H股总数211,200,000股的0.86%,购股均价为每股25.94港元。2026年10月09日,该股收市价为32.36港元。连同2026年06月28日已授出的33,400股,本年度公司已向梁栋科博士累计授出1,856,400股H股,均在其个人限额5,210,000股以内。梁栋科博士及其联繫人宋媛博士已回避相关董事会表决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674848828","title":"瑛泰医疗拟“回A”,搭建A+H双资本运作平台,拓宽融资渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2674848828","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674848828?lang=zh_cn&edition=full","pubTime":"2026-10-12 10:08","pubTimestamp":1791770896,"startTime":"0","endTime":"0","summary":"10月11日,瑛泰医疗(01501.hk)公告称,公司董事会审议通过建议A股发行及相关事宜,拟申请A股发行并在深交所创业板上市,以依托港股、A股两地资本市场协同优势,搭建双资本运作平台,拓宽融资渠道,优化公司资本结构,提升综合竞争力,并实现公司长期稳健发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610123892449728.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610123892449728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817416","title":"瑛泰医疗(01501):建议发行总数不超过3727.06万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817416","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674817416?lang=zh_cn&edition=full","pubTime":"2026-10-11 19:43","pubTimestamp":1791719024,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗 发布公告,董事会已审议通过建议A股发行,以依托港股、A股两地资本市场协同优势,搭建双资本运作平台,拓宽融资渠道,优化本公司资本结构,提升综合竞争力,并实现本公司长期稳健发展。本次拟公开发行人民币普通股(A股)总数不超过3727.06万股A股,占本公司于本公告日期已发行股本总额不超过约17.65%,且不超过本公司经配发及发行A股扩大后已发行股本总额15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07233","159982","82822","02843","02823","BK1222","82843","02827","83130","BK1147","01501","03188","82823","BK1610","03130","399300","02846","02822","83188","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108077230","title":"瑛泰医疗(01501)董事会通过A股发行方案 拟募资18亿元拓展医疗器械产业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1108077230","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108077230?lang=zh_cn&edition=full","pubTime":"2026-10-11 19:31","pubTimestamp":1791718278,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司10月11日公告称,董事会在第四届董事会第十三次会议上审议通过多项决议,核心包括拟进行A股公开发行并在深圳证券交易所创业板上市、采纳A股上市后适用的公司章程和治理制度,以及修订H股奖励信托计划。相关议案将提交公司2026年第二次临时股东大会审议。瑛泰医疗拟公开发行不超过37,270,588股人民币普通股(A股),约占本公告日期已发行股本总额的17.65%,且不超过发行完成后扩大后已发行股本总额的15%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124694298","title":"瑛泰医疗9月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1124694298","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124694298?lang=zh_cn&edition=full","pubTime":"2026-10-07 21:36","pubTimestamp":1791380182,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年10月7日发布2026年9月股份变动月报表。公告显示,截至2026年9月30日,该公司已发行普通股本211,200,000股,注册资本为人民币211,200,000元,公司股本总数较上月底未发生增减。报告期内,瑛泰医疗并无新增发行、购回或注销股份,也无任何库藏股变动。公告同时披露,报告期内未有与股份期权、认股权证或可换股票据相关的变动记录,也不存在任何其他可能导致股本变动的协议或安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155308548","title":"瑛泰医疗(01501)公布最新董事会及专门委员会架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1155308548","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155308548?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:36","pubTimestamp":1790242608,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司9月24日发布公告,披露新一届董事会成员及其在四个董事委员会中的任职情况。董事会由9名董事组成,包括2名执行董事、4名非执行董事及3名独立非执行董事。公司设立审计委员会、薪酬委员会、提名委员会以及战略与可持续发展委员会四个专门委员会,各委员会主席及成员分工情况如下:。公告显示,林森先生、陈红琴女士及张泓先生目前未在任何专门委员会担任职务。上述任命自2026年9月24日起生效。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122652167","title":"瑛泰医疗2026年第一次临时股东会全部议案获通过 董事会及专门委员会架构同步调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1122652167","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122652167?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:36","pubTimestamp":1790242566,"startTime":"0","endTime":"0","summary":"2026年9月24日,上海瑛泰医疗器械股份有限公司在中国上海召开2026年第一次临时股东会,对5项议案进行表决,全部获股东通过。根据上市规则第17.05A条,H股奖励信托计划受托人持有的435.64万股放弃投票。\\n\\n董事会及专门委员会同步调整:\\n 张鹏博士、黎云龙博士正式出任独立非执行董事,任期自股东会批准之日起至第四届董事会任期届满。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669158466","title":"瑛泰医疗(01501.HK):张鹏及黎云龙获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2669158466","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669158466?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:29","pubTimestamp":1790242196,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159864537","title":"瑛泰医疗2026年中期营收5.96亿元,经调整净利润1.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159864537","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159864537?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:38","pubTimestamp":1789375082,"startTime":"0","endTime":"0","summary":"瑛泰医疗披露的2026年中期报告显示,期内实现营收5.96亿元,同比提升29.28%。期内整体毛利为3.64亿元,同比提升34.63%,毛利率从上年同期的58.70%上升至61.13%。经调整净利润录得1.26亿元,较上年同期的1.02亿元增长22.68%。经营活动所得净现金流为2.12亿元,相较上年同期的1.23亿元大幅提升72.86%。研发投入从上年同期的0.92亿元增加至1.03亿元,占营收比重保持相对稳定。介入医疗器械业务在报告期内实现收入5.34亿元,同比增长36.07%。代理业务收入为0.19亿元,同比下降41.59%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗2026年中期营收5.96亿元,经调整净利润1.26亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159523311","title":"瑛泰医疗(01501)拟1.73亿美元收购心瓣介入器械商约27.82%股权 目标公司2025年收入增逾一倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1159523311","media":"公告速递","labels":["shareholding","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159523311?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:40","pubTimestamp":1789137648,"startTime":"0","endTime":"0","summary":"2026年9月11日,瑛泰医疗器械股份有限公司公告,已与多家独立第三方卖方签署协议,拟以1.7288亿美元收购目标公司合计3,613,909股股份,包括2,164,770股普通股、400,788股A轮优先股及1,628,217股B轮优先股。若后续股份调整完成,瑛泰医疗持股比例预计上升至35.62%。瑛泰医疗表示,收购完成并取得控制权后,可与其现有主动脉瓣产品形成协同,补足在二尖瓣及三尖瓣介入治疗的产品空白,完善结构性心脏病全线布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173310590","title":"瑛泰医疗(01501)2026年9月24日召开临时股东大会 拟调整董事会及修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=1173310590","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173310590?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:15","pubTimestamp":1788858921,"startTime":"0","endTime":"0","summary":"关键信息: \n1.会议时间:2026年9月24日14:00 \n2.地点:上海市嘉定区金园一路925号2幢 \n3.股权登记日:2026年8月24日16:30前;名册暂停期:8月25日至9月24日 \n4.股东可委任代理出席并投票,会议预计不超半天\n股东大会要点: \n普通决议 \n① 选聘张鹏博士、黎云龙博士为第四届董事会独立非执行董事 \n② 提高董事长梁栋科博士在H股奖励信托计划下的个人限额\n特别决议 \n① 修订《公司章程》,以配合最新监管与治理需要 \n② 修订《董事会议事规则》,优化董事会运作","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119957422","title":"瑛泰医疗2026年8月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1119957422","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119957422?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:01","pubTimestamp":1788339705,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司于2026年9月2日发布2026年8月股份变动月报表,披露自2026年8月1日至2026年8月31日的股份变动及股本结构等情况。公告显示,公司于本月无新增发行或库藏股变动。截至2026年8月31日,普通股(H股)股本月末结余数为211,200,000股,较上月底维持不变,面值为每股人民币1元,注册资本总额仍为人民币211,200,000元。本次公告由公司董事会主席兼执行董事梁栋科签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271669","title":"瑛泰医疗(01501):王瑞琴辞任公司非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271669","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661271669?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:18","pubTimestamp":1787577529,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗 发布公告,王瑞琴先生因个人工作安排调整,已提呈辞任公司非执行董事,自2026年8月24日起生效。蹇锡高先生及许鸿群先生自2018年12月8日起担任公司独立非执行董事,至今连续任职已超过七年。蹇锡高先生及许鸿群先生的辞任将自新任独立非执行董事正式就任之日起生效。建议委任独立非执行董事尚须待股东于临时股东会上以普通决议案方式批准后,方可作实,并将自临时股东会批准之日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01501","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188325882","title":"瑛泰医疗(01501)多项董事会人事及治理结构调整 拟向董事长授出最多521万股H股奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1188325882","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188325882?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577344,"startTime":"0","endTime":"0","summary":"2026年8月24日,上海瑛泰医疗器械股份有限公司发布多项董事会及公司治理相关公告,主要内容如下:。非执行董事王瑞琴先生因个人工作安排调整,已向公司提出辞任非执行董事,自2026年8月24日起生效。其辞任自新任独立非执行董事就任之日起生效。董事会建议委任张鹏博士(59岁)及黎云龙博士(58岁)为第四届董事会独立非执行董事候选人,任期自临时股东会批准之日起至本届董事会届满。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140403589","title":"瑛泰医疗(01501)公布最新董事会及三大专门委员会成员名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1140403589","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140403589?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577341,"startTime":"0","endTime":"0","summary":"公告中未披露其他财务数据。公司强调,本次披露为例行性信息更新,旨在让投资者及时掌握公司董事会及专门委员会的人员安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168381491","title":"瑛泰医疗(01501)发布2026年中期业绩:营收5.96亿元 同比增29% 毛利率升至61.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168381491","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168381491?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577339,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司8月24日披露截至2026年6月30日止六个月未经审核中期业绩。期内,公司实现收入5.9606亿元,同比增长29.28%;归属于公司股东的净利润1.2567亿元,同比增长22.68%。报告期内,公司毛利3.6438亿元,同比增加34.63%;毛利率由58.70%升至61.13%。公司解释,毛利率提升主要源于收购并购完善产品品类矩阵,以及毛利率相对较低的代理业务收入占比下降。成本及费用方面,销售成本2.3168亿元,同比增加21.67%。期内所得税费用1,901.4万元,实际所得税率13.14%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661527130","title":"瑛泰医疗(01501)发布中期业绩,股东应占利润1.1亿元 同比增加11.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661527130","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661527130?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:15","pubTimestamp":1787577302,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑛泰医疗(01501)发布截至2026年6月30日止6个月中期业绩,该集团取得收入5.96亿元,同比增加29.28%;公司权益股东应占利润1.1亿元,同比增加11.97%;每股盈利0.54元。公告称,收入增加主要是由于收购及并购填补了产品缺口,构建了完整的产品品类矩阵;以及透过渠道复用及供应链整合实现协同效应,从而推动介入医疗器械销量增长所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑛泰医疗(01501)发布中期业绩,股东应占利润1.1亿元 同比增加11.97%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108635189","title":"瑛泰医疗(01501)定于8月24日审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1108635189","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108635189?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524355,"startTime":"0","endTime":"0","summary":"上海瑛泰医疗器械股份有限公司(01501)8月12日公告,公司董事会将于2026年8月24日(星期一)召开会议,主要议程包括:一是审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审核中期业绩,以供发布;二是考虑宣派中期股息(如有)。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01501"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kdlchina.com","stockEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.1063},{"period":"3month","weight":-0.1125},{"period":"6month","weight":-0.2035},{"period":"1year","weight":-0.0032},{"period":"ytd","weight":0.0287}],"compareEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0618},{"period":"6month","weight":-0.0895},{"period":"1year","weight":-0.0913},{"period":"ytd","weight":-0.0772}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海瑛泰医疗器械股份有限公司(原名:上海康德莱医疗器械股份有限公司)是一家主要从事心内介入器械研发、生产和销售的中国公司。该公司通过两个分部运营其业务。心内介入业务分部主要从事心内介入医疗器械及相关模具、标准件、面罩的销售、制造和研发。其他分部从事其他介入医疗器械的研发,例如神经介入医疗器械、心脏瓣膜植入式医疗器械。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.045707},{"month":2,"riseRate":0.285714,"avgChangeRate":0.009958},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.013734},{"month":4,"riseRate":0.714286,"avgChangeRate":0.03758},{"month":5,"riseRate":0.285714,"avgChangeRate":0.072512},{"month":6,"riseRate":0.428571,"avgChangeRate":0.055661},{"month":7,"riseRate":0.714286,"avgChangeRate":0.022949},{"month":8,"riseRate":0.714286,"avgChangeRate":0.026536},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.067259},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041877},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.077012},{"month":12,"riseRate":0.714286,"avgChangeRate":0.030589}],"exchange":"SEHK","name":"瑛泰医疗","nameEN":"INT MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑛泰医疗,01501,瑛泰医疗股票,瑛泰医疗股票老虎,瑛泰医疗股票老虎国际,瑛泰医疗行情,瑛泰医疗股票行情,瑛泰医疗股价,瑛泰医疗股市,瑛泰医疗股票价格,瑛泰医疗股票交易,瑛泰医疗股票购买,瑛泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑛泰医疗(01501)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑛泰医疗(01501)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}